Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Caleres
CAL
$463M
| $24.2M | 0.06% |
859,050
+435,600
| +103% | +$10.7M |
|
|
WLL
402
DELISTED
Whiting Petroleum Corporation
WLL
| $24.2M | 0.06% |
+1,302
| New | +$24.6M |
|
|
KYO
403
DELISTED
Kyocera Adr
KYO
| $24.2M | 0.06% |
481,800
-2,800
| -0.6% | -$143K |
|
|
SLXP
404
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $24.2M | 0.06% |
268,519
+6,419
| +2% | +$512K |
|
|
N
405
DELISTED
Netsuite Inc
N
| $24.1M | 0.06% |
234,400
+103,700
| +79% | +$10.4M |
|
|
AEPI
406
DELISTED
AEP Industries Inc
AEPI
| $24.1M | 0.06% |
456,246
+191,991
| +73% | +$10.8M |
|
|
SNV
407
DELISTED
Synovus
SNV
| $24.1M | 0.06% |
954,814
+96,300
| +11% | +$2.27M |
|
|
ARRS
408
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $24M | 0.06% |
988,020
+330,400
| +50% | +$6.3M |
|
409
A.O. Smith
AOS
$8.49B
| $24M | 0.06% |
890,800
+35,800
| +4% | +$917K |
|
|
FLIR
410
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $23.9M | 0.06% |
794,860
-511,100
| -39% | -$15.1M |
|
|
CPN
411
DELISTED
Calpine Corporation
CPN
| $23.8M | 0.06% |
1,221,700
+363,900
| +42% | +$7.07M |
|
|
ELNK
412
DELISTED
EarthLink Holdings Corp.
ELNK
| $23.6M | 0.06% |
4,650,100
-1,000,300
| -18% | -$5.11M |
|
|
SAFM
413
DELISTED
Sanderson Farms Inc
SAFM
| $23.5M | 0.06% |
324,917
+258,600
| +390% | +$17.2M |
|
|
BPL
414
DELISTED
Buckeye Partners, L.P.
BPL
| $23.5M | 0.06% |
330,734
-27,100
| -8% | -$1.82M |
|
415
Intercontinental Exchange
ICE
$87.2B
| $23.4M | 0.06% |
520,990
-1,516,010
| -74% | -$62.4M |
|
|
BRS
416
DELISTED
Bristow Group, Inc.
BRS
| $23.4M | 0.06% |
312,200
+33,100
| +12% | +$2.59M |
|
|
WEB
417
DELISTED
Web.com Group, Inc.
WEB
| $23.4M | 0.06% |
734,900
+330,900
| +82% | +$9.62M |
|
|
SWI
418
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $23.3M | 0.06% |
615,900
+314,500
| +104% | +$11M |
|
419
Spok Holdings
SPOK
$229M
| $23.3M | 0.06% |
1,630,900
+64,600
| +4% | +$935K |
|
|
TARO
420
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $23.3M | 0.06% |
235,473
+22,373
| +10% | +$1.94M |
|
421
Boston Beer
SAM
$1.9B
| $23.1M | 0.06% |
95,700
+5,800
| +6% | +$1.39M |
|
|
WIBC
422
DELISTED
WILSHIRE BANCORP INC
WIBC
| $22.9M | 0.05% |
2,093,576
+125,201
| +6% | +$1.18M |
|
423
Nordson
NDSN
$17.2B
| $22.6M | 0.05% |
304,814
+261,600
| +605% | +$19M |
|
424
Grupo Aeroportuario del Sureste
ASR
$8.02B
| $22.6M | 0.05% |
181,500
-9,300
| -5% | -$1.15M |
|
|
ACC
425
DELISTED
American Campus Communities, Inc.
ACC
| $22.3M | 0.05% |
690,828
+323,900
| +88% | +$10.9M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.